Valeant Pharmaceuticals Intl Inc (VRX) Option Bulls Strike Again

Valeant Pharmaceuticals Intl Inc's December 135 call is again being bought to open

Digital Content Group
Nov 13, 2014 at 2:16 PM
facebook twitter linkedin


Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has barely budged this afternoon, up 0.1% at $131.27, as traders continue to tread cautiously ahead of a potential deal with Allergan, Inc. (NYSE:AGN). Nevertheless, option speculators have been busy today, with VRX calls running at five times the expected intraday clip. Plus, the stock's 30-day at-the-money implied volatility (IV) has risen 2% to 48.8%, signaling elevated demand for short-term strikes.

Garnering the most action for the second day in a row is VRX's December 135 call, where roughly 3,300 contracts have changed hands. Four-fifths of theses calls have traded at the ask price, IV is higher, and data from Trade-Alert points to freshly minted bullish bets. In other words, today's buyers expect the stock to topple the near-the-money strike by the close on Friday, Dec. 19, when back-month options expire.

Historically speaking, $135 has been a tough nut to crack for Valeant Pharmaceuticals Intl Inc (NYSE:VRX). In fact, the shares haven't closed above this level since early May. Nevertheless, delta on the call sits at 0.46, signifying an almost 1-in-2 probability the option will be in the money at expiration.

 

Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 

 


 


 
Special Offers from Schaeffer's Trading Partners